TVTX Travere Therapeutics, Inc.

NEUTRAL Impact: 2/10 Insider Cluster (2 insiders)
Horizon immediate Filed Jun 16, 2026 Processed 2d 12h ago
Insider cluster: 2 insiders, $726K total
Latest settled — T+1d ⚠ clustered
TVTX ▲ +1.87% at T+1d
NEUTRAL call ✓ call won +1.87% · α vs SPY +1.09% · entry $54.14 → $55.15
Next anchor: T+5d in 5d
Last close $54.14 (close Jun 17) · -0.00% from $54.14 entry
Entry anchored
Jun 16, 03:59 PM ET
via Databento tick
T+1d
+1.87%
call +1.87% · α +1.09%
$55.15
settled yesterday
T+5d
call — · α —
in 5d
T+20d
call — · α —
in 26d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

Two directors of Travere Therapeutics (TVTX) exercised stock options and immediately sold the resulting shares on June 12, 2026, for a total of ~$726K in open-market sales. The combined sales represent only 0.015% of the company's $5.0B market cap, making this a routine, liquidity-driven transaction with no material informational content.

Key Financial Metrics

Direction
selling
Total Value
$725.7K
Insiders
2

Actionable Insight

This insider cluster is routine and non-informative. No trading action is warranted based on these small director sales. Monitor for any upcoming corporate events (e.g., earnings, pipeline updates) that could provide a catalyst, but this filing alone does not change the outlook.

Key Facts

  • Directors Timothy Coughlin and Roy D. Baynes each exercised stock options and sold shares on June 12, 2026.
  • Coughlin sold 10,000 shares at $50.07 for $500,747; Baynes sold 4,500 shares at $50.00 for $225,000.
  • Total open-market sales: $725,747, or ~0.015% of TVTX's $5.0B market cap.
  • Both sales followed option exercises (cash and non-cash), indicating a typical exercise-and-sell pattern rather than a bearish signal.
  • No C-suite executives participated in the cluster; only directors transacted.

Financial Impact

Trivial — $726K in sales is immaterial relative to $5.0B market cap.

dilutioninsider ownership

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (21 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TVTX-1781642857007
15 reports for TVTX
Performance horizon
100% Hit rate 7 of 7 directional calls best @ T+60▲ +49.98%Feb 28, 2026
Filters
Rows
Reports for TVTX — sortable, filterable
Type Now
Jun 16, 2026
2d ago
Insider Cluster
NEUTRAL ★ 2/10
$54.14 $55.15▲ +1.87%▲ +1.09%$54.14 (−0.00%)
Jun 16, 2026
2d ago
8-K
NEUTRAL ★ 2/10
$54.14 $55.15▲ +1.87%▲ +1.09%$54.14 (−0.00%)
Jun 12, 2026
6d ago
144
NEUTRAL ★ 2/10
$52.04 $53.80▲ +3.38%▲ +1.62%$54.14 (+4.04%)
Jun 2, 2026
16d ago
8-K
BULLISH ★ 6/10
$42.96 $45.20▲ +5.21%▲ +5.94%$54.14 (+26.02%)
May 15, 2026
4w ago
144
NEUTRAL ★ 2/10
$42.59 $42.89▲ +0.70%▲ +0.77%$54.14 (+27.12%)
May 5, 2026
6w ago
144
NEUTRAL ★ 2/10
$44.76 $42.66▼ −4.69%▼ −4.36%$54.14 (+20.96%)
May 4, 2026
6w ago
144
NEUTRAL ★ 3/10
$44.80 $44.80· 0.00%▼ −1.38%$54.14 (+20.85%)
May 1, 2026
7w ago
Insider Cluster
BEARISH ★ 6/10
$44.12 $44.91▼ −1.79%▼ −2.13%$54.14 (−22.71%)
Apr 15, 2026
9w ago
144
NEUTRAL ★ 3/10
$40.95 $39.54▼ −3.44%▼ −3.70%$54.14 (+32.21%)
Apr 15, 2026
9w ago
Insider Cluster
BEARISH ★ 7/10
$40.95 $39.54▲ +3.44%▲ +3.70%$54.14 (−32.21%)
Showing 10 of 15

US Market Status

Market Closed — Juneteenth — Opens Mon (76h 13m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access